The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,807.50
Ask: 1,808.50
Change: 10.50 (0.58%)
Spread: 1.00 (0.055%)
Open: 1,797.00
High: 1,810.00
Low: 1,792.00
Prev. Close: 1,799.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Bank rules force staff to turn off NHS COVID-19 tracing app at work

Thu, 08th Oct 2020 13:32

* Thousands of staff seen at risk of undetected infection -
union

* Some banks ask staff to store phones away to prevent data
leaks

* Govt advises NHS app should be paused if phone not on
person
(Adds Department of Health comment)

By Iain Withers and Sinead Cruise

LONDON, Oct 8 (Reuters) - Branch staff at some of Britain's
biggest banks say rules that require them to store phones in
lockers while at work are putting them at undue risk of COVID-19
from colleagues and customers, as they cannot use the country's
tracing app.

Lloyds Banking Group, along with rival TSB, are
among those advising employees to deactivate the NHS Track &
Trace app during office hours, when they are not allowed to keep
phones on their person.

Some banks ask staff and cashiers to store phones away to
prevent leaks of sensitive customer data, although this is not
formally required by regulator the Financial Conduct Authority.

Under current government guidelines, users of the NHS app
are advised to disable bluetooth or pause the app when away from
their phones to avoid false notifications.

Other companies have told staff to pause the app at work,
including pharmaceuticals firm GSK, which said its other
safety measures were sufficient, the Guardian newspaper
reported.

The BTU union, which represents staff working for Lloyds but
is not recognised by the bank, said it had been contacted by
dozens of staff unable to use the app, which has been downloaded
by more than 14 million people.

One unnamed Lloyds employee who contacted the BTU said: "I
live and work in a high-risk area so I am very concerned at
being told that while I'm at work I have to suspend the NHS test
and trace app... This defeats the object of track and trace."

Another said they were at risk as they had to conduct
face-to-face meetings and due to the "blatant transgression of
the social distancing rules by many customers".

"Customers and staff have a right to know if they have come
into contact with someone who's been infected," said Mark Brown,
general secretary of the BTU.

Although several European countries have launched
Bluetooth-based apps to alert those at risk of catching
COVID-19, there is little evidence to date that the technology
has significantly curbed infections.

Both Lloyds and TSB have advised staff to pause the app's
tracing function while at work, according to internal guidance
issued by each lender seen by Reuters.

"Colleagues who have downloaded the app to their own smart
phone should not use the app while you are at work," Lloyds told
staff, adding it was to stop people receiving false alerts.

A NatWest spokesman said the bank encouraged staff to use
the app but said they should pause it when they are not with
their phone. The bank discourages - though doesn't ban - the use
of personal phones in branches and contact centres.

A spokesman for Barclays said the bank had not advised staff
to turn off the app.

A Department of Health and Social Care spokeswoman said: "We
want as many people to download and use the app as possible. It
is important to use the NHS Covid-19 app at all times, including
while at work, unless in specific scenarios which are clearly
set out in our guidance."

TSB was not immediately available for comment. Lloyds
declined to comment.

A second employee union, Accord, said rules prohibiting use
of personal phones in the workplace were in place to protect
employees from security risks.

"If customers care about the health and well-being of the
bank staff they rely on, they could help by wearing face
coverings when visiting bank branches," Accord's General
Secretary Ged Nichols said.
(Reporting by Iain Withers and Sinead Cruise; Additional
reporting by Douglas Busvine in Berlin; Editing by Rachel
Armstrong, Jan Harvey and Toby Chopra)

More News
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.